BB Biotech AG

Swiss Stock Exchange:BION.SW

Sector

🏥 Health Care

Industries

🧬 Biotechnology

💰 Hedge Funds

💼 Private Equity

Location

Switzerland

Market Cap

USD 2.15 B

Share Price

USD 39.23

Avg Daily Volume

82,332

Change (1 day)

0.19%

Change (1 year)

-17.11%

Change (YTD)

0.23%

BB Biotech AG Receivables for the year ending December 31, 2018: USD 0.00

BB Biotech AG Receivables is USD 0.00 for the year ending December 31, 2018. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Competitors

Blackstone Inc.

USD 159.80

-3.56 -2.18%

Apollo Global Management, Inc.

USD 145.72

APO

-2.81 -1.89%

MSCI Inc.

USD 563.13

MSCI

-7.53 -1.32%

The Carlyle Group Inc.

USD 57.64

-1.33 -2.25%

Legal & General Group Plc

USD 3.39

LGEN.L

-0.03 -1.01%

Investment AB Latour (publ)

USD 25.68

LATO-B.ST

-0.09 -0.35%

Ares Capital Corporation

USD 22.75

ARCC

-0.11 -0.48%

Washington H. Soul Pattinson and Company Limited

USD 26.80

SOL.AX

-0.01 -0.04%

Kingdom Holding Company

USD 2.24

4280.SR

+0.02 0.84%

Intermediate Capital Group plc

USD 26.45

ICG.L

-0.25 -0.95%

Zegona Communications plc

USD 9.90

ZEG.L

-0.17 -1.68%

StepStone Group Inc.

USD 58.85

STEP

-1.12 -1.87%

Vontobel Holding AG

USD 85.07

VONN.SW

-0.52 -0.61%

Bridgepoint Group plc

USD 4.48

BPT.L

-0.03 -0.58%

Quilter plc

USD 2.22

QLT.L

+0.01 0.44%

Caledonia Investments plc

USD 48.23

CLDN.L

-0.71 -1.44%

HarbourVest Global Private Equity Ltd.

USD 33.92

HVPE.L

+0.15 0.45%

Grosvenor Capital Management, L.P.

USD 11.64

GCMG

-0.15 -1.27%

Ninety One Group

USD 2.46

NY1.JO

+0.02 0.75%

Pantheon International PLC

USD 4.26

PIN.L

-0.00 -0.03%

Key Data

Date	Receivables	Inventory	Current Assets	Property, Plant, Equipment (Net)